Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IRCT20141201020178N9Phase 2Completed
Phase 2, open-label trial of diosmin in hemorrhoid (2 arms), sponsored by Iran University of Medical Sciences. Primary endpoints: Anal pain score, Bleeding status and 1 more. Started Apr 2018; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on IRCT20141201020178N9.